Ulf Wiinberg appointed new CEO of Lundbeck

05-May-2008

The Supervisory Board of H. Lundbeck A/S has appointed Ulf Wiinberg as new president and CEO of Lundbeck. Ulf Wiinberg will take up his new position on 1 June 2008.

Ulf Wiinberg will be leaving the US pharmaceutical company Wyeth, where he has been responsible for two areas: Strategic oversight of Wyeth's biopharma activities and as President of Wyeth Europe, Middle East, Africa and Canada.

Lundbeck's future president and CEO started his pharmaceutical career in Sweden in 1981 and has worked for Wyeth for 27 years, where he has held management positions in Europe as well as in the USA. Ulf Wiinberg distinguishes himself by his strong commercial competencies and has achieved a number of significant results at Wyeth.

Ulf Wiinberg was previously responsible for Wyeth Consumer Healthcare Products and Managing Director of Wyeth in the UK. Ulf Wiinberg has served as a member of Wyeth's management committee as well as of the corporation's operations committee, legal committee and HR committee.

Ulf Wiinberg is 49 years old, married and has four children. He is a Danish citizen who was born and raised in Sweden, and has lived and worked for five years in the UK and 13 years in the USA. In connection with his new position, Ulf Wiinberg will move to Denmark from New Jersey, USA.

Other news from the department people

Most read news

More news from our other portals

Discover the latest developments in battery technology!